Oss, Netherlands

Hubert Jan Jozef Loozen

This inventor holds 18 USPTO granted patents and 4 published patent applications and 5 EPO patents, primarily in Steroid Chemistry. Top assignees: Akzo Nobel N.v., N.v. Organon, Merck Sharp + Dohme B.v.. Active years: 2001-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hubert Jan Jozef Loozen. Retrieved from https://idiyas.com/inventor/hubert-jan-jozef-loozen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 61.1

 

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • AC Uden, NL (2005)
  • Meerhoek, NL (2009)
  • Uden, NL (2001 - 2011)
  • Oss, NL (2007 - 2013)

Company Filing History:


Years Active: 2001-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Steroid Compounds
Estrogenic Activity
Androgens
Women's Healthcare
Dihydropyrrolo
Tetrahydrobenzfluorene
Non-aromatic Steroids
Contraceptive Activity
Anti-osteoporosis
Selective Estrogens
Menopausal Treatments
Dihydrobenzoindazoles
18 patents (USPTO):Explore Patents

Title: Innovator Hubert Jan Jozef Loozen: Pioneering Women's Health Solutions

Introduction

Hubert Jan Jozef Loozen, a prolific inventor based in Oss, Netherlands, has made significant contributions to the field of pharmaceutical innovations, particularly in women's healthcare. With an impressive portfolio of 18 patents, Loozen has focused his efforts on creating compounds that address both infertility and various hormonal disorders.

Latest Patents

Among his latest inventions are two notable patents. The first is related to ring-annulated dihydropyrrolo[2,1-α]isoquinoline compounds, which are described as either the compounds themselves or their pharmaceutically acceptable salts. These innovations have potential applications in treating infertility, showcasing Loozen's commitment to improving reproductive health.

The second patent addresses substituted 16,17-annellated steroid compounds intended for women's healthcare. This invention encompasses a diverse range of applications, including the treatment and prevention of endometriosis, contraception, hormonal therapy for perimenopausal and post-menopausal women, as well as addressing osteoporotic issues and menstrual-related disorders. The breadth of these applications underscores the importance of his work in advancing women's health.

Career Highlights

Throughout his career, Hubert Jan Jozef Loozen has collaborated with notable companies such as Akzo Nobel N.V. and N.V. Organon. His work in these leading organizations has facilitated the development of innovative solutions that have the potential to alleviate significant health concerns.

Collaborations

Loozen has also had the pleasure of working alongside esteemed colleagues, including Dirk Leysen and Jaap Van Der Louw. These collaborations have not only enriched his research but have also led to the fruitful exchange of ideas, driving innovation in pharmaceutical applications.

Conclusion

In summary, Hubert Jan Jozef Loozen stands out as an influential figure in the realm of pharmaceutical inventions, particularly in the area of women’s health. His dedication to creating effective solutions for infertility and other hormonal disorders is reflected in his extensive patent portfolio. As he continues to innovate through his research, Loozen's contributions are likely to have a lasting impact on healthcare initiatives and the wellbeing of women worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…